Risk/ benefit- ratio af sildenafil er ikke fastslået hos patienter med klasse I i den funktionelle klassificering af pulmonal arteriel hypertension.
The benefit-risk balance of sildenafil has not been established in patients with class I functional classification of pulmonary arterial hypertension.